SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 24 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,333 | -34.2% | 25,774 | 0.0% | 0.00% | – |
| Q2 2023 | $29,382 | -24.0% | 25,774 | 0.0% | 0.00% | – |
| Q1 2023 | $38,661 | -49.7% | 25,774 | -50.0% | 0.00% | – |
| Q4 2022 | $76,806 | +92.0% | 51,548 | +100.0% | 0.00% | – |
| Q3 2022 | $40,000 | -32.2% | 25,774 | 0.0% | 0.00% | – |
| Q2 2022 | $59,000 | -88.7% | 25,774 | -88.6% | 0.00% | – |
| Q1 2022 | $521,000 | -57.3% | 225,572 | +7.3% | 0.00% | – |
| Q4 2021 | $1,220,000 | -31.0% | 210,292 | +25.2% | 0.00% | – |
| Q3 2021 | $1,768,000 | +81.1% | 168,031 | +68.0% | 0.00% | – |
| Q2 2021 | $976,000 | +14.3% | 100,000 | +70.2% | 0.00% | – |
| Q1 2021 | $854,000 | – | 58,771 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Duquesne Family Office | 100,000 | $231,000 | 0.01% |
| FNY Investment Advisers, LLC | 3,500 | $8,000 | 0.01% |
| LEO BROKERAGE, LLC | 14,845 | $34,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 37,900 | $88,000 | 0.00% |
| UBS Group AG | 13,618 | $31,000 | 0.00% |
| RHUMBLINE ADVISERS | 16,169 | $37,000 | 0.00% |
| Ellevest, Inc. | 19 | $0 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 62,184 | $144,000 | 0.00% |
| FMR LLC | 179 | $0 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 10,375 | $24,000 | 0.00% |